in the expression of miRNAs)
and designing their
targeted therapy using specific miRNAs as
targets. This article
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) studies in clinical laboratories. In addition, the question of the
target orientation of exosomes
processes of VTCs for effective
therapy and diagnosis. Significant progress has been made in VTC research
Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) effectively
target various structures within the central nervous system (CNS). MiRNA-based
therapy stands out
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) resistance and promising directions for
targeted therapy. This review presents the results of scientific
Beylerli, Ozal,
Ju, Jiaming,
Beilerli, Aferin,
Gareev, Ilgiz,
Shumadalova, Alina,
Ilyasova, Tatiana,
Bai, Yunlong,
Yang, Baofeng (2023) drug
therapy for AF patients is often ineffective and may have adverse effects. Radiofrequency ablation